Search research articles
Contact Us
Filters
Showing results (101-110 of 204) with videos related to
Page
of 21
Sort By:
Tuberculosis (Edinburgh, Scotland)
|
October 9, 2022
Challenges and a potential solution to perform drug susceptibility testing of omadacycline against nontuberculous mycobacteria
Prem Shankar, Sanjay Singh, Gunavanthi D Boorgula, et al.
Tuberculosis (Edinburgh, Scotland)
|
December 13, 2022
Isoniazid pharmacokinetics/pharmacodynamics as monotherapy and in combination regimen in the hollow fiber system model of Mycobacterium kansasii
Gunavanthi D Boorgula, Sanjay Singh, Prem Shankar, et al.
The Journal of Infectious Diseases
|
August 1, 2013
Serum drug concentrations predictive of pulmonary tuberculosis outcomes
Jotam G Pasipanodya, Helen McIlleron, André Burger, et al.
Scandinavian Journal of Infectious Diseases
|
February 13, 2003
Late complications of Candida (Torulopsis) glabrata fungemia: description of a phenomenon
Tawanda Gumbo, Roy F Chemaly, Carlos M Isada, et al.
The Journal of Antimicrobial Chemotherapy
|
November 10, 2023
Sarecycline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium avium complex: so near and yet so far
Sanjay Singh, Gunavanthi D Boorgula, Santosh Aryal, et al.
Frontiers in Pharmacology
|
May 3, 2021
Comparison of Rifamycins for Efficacy Against <i>Mycobacterium avium</i> Complex and Resistance Emergence in the Hollow Fiber Model System
Gunavanthi D Boorgula, Laxmi U M R Jakkula, Tawanda Gumbo, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2005
Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity
Arnold Louie, Mark Deziel, Weiguo Liu, et al.
Antimicrobial Agents and Chemotherapy
|
July 27, 2016
Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis
Shashikant Srivastava, Chawanga Modongo, Chandima W Siyambalapitiyage Dona, et al.
The Journal of Antimicrobial Chemotherapy
|
March 8, 2022
Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses
Moti Chapagain, Jotam G Pasipanodya, Shruti Athale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2016
A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground
Shashikant Srivastava, Devyani Deshpande, Jotam G Pasipanodya, et al.
Page
of 21
Search research articles
Search
Showing results (101-110 of 204) with videos related to
Sort By:
Page
of 21
Tuberculosis (Edinburgh, Scotland)
|
October 9, 2022
Challenges and a potential solution to perform drug susceptibility testing of omadacycline against nontuberculous mycobacteria
Prem Shankar, Sanjay Singh, Gunavanthi D Boorgula, et al.
Tuberculosis (Edinburgh, Scotland)
|
December 13, 2022
Isoniazid pharmacokinetics/pharmacodynamics as monotherapy and in combination regimen in the hollow fiber system model of Mycobacterium kansasii
Gunavanthi D Boorgula, Sanjay Singh, Prem Shankar, et al.
The Journal of Infectious Diseases
|
August 1, 2013
Serum drug concentrations predictive of pulmonary tuberculosis outcomes
Jotam G Pasipanodya, Helen McIlleron, André Burger, et al.
Scandinavian Journal of Infectious Diseases
|
February 13, 2003
Late complications of Candida (Torulopsis) glabrata fungemia: description of a phenomenon
Tawanda Gumbo, Roy F Chemaly, Carlos M Isada, et al.
The Journal of Antimicrobial Chemotherapy
|
November 10, 2023
Sarecycline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium avium complex: so near and yet so far
Sanjay Singh, Gunavanthi D Boorgula, Santosh Aryal, et al.
Frontiers in Pharmacology
|
May 3, 2021
Comparison of Rifamycins for Efficacy Against <i>Mycobacterium avium</i> Complex and Resistance Emergence in the Hollow Fiber Model System
Gunavanthi D Boorgula, Laxmi U M R Jakkula, Tawanda Gumbo, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2005
Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity
Arnold Louie, Mark Deziel, Weiguo Liu, et al.
Antimicrobial Agents and Chemotherapy
|
July 27, 2016
Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis
Shashikant Srivastava, Chawanga Modongo, Chandima W Siyambalapitiyage Dona, et al.
The Journal of Antimicrobial Chemotherapy
|
March 8, 2022
Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses
Moti Chapagain, Jotam G Pasipanodya, Shruti Athale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2016
A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground
Shashikant Srivastava, Devyani Deshpande, Jotam G Pasipanodya, et al.
Page
of 21